The isopeptidase inhibitor 2cPE triggers proteotoxic stress and ATM activation in chronic lymphocytic leukemia cells. - sprookjes - yvandenbroek - TriplyDB

The isopeptidase inhibitor 2cPE triggers proteotoxic stress and ATM activation in chronic lymphocytic leukemia cells.

The isopeptidase inhibitor 2cPE triggers proteotoxic stress and ATM activation in chronic lymphocytic leukemia cells.

http://www.wikidata.org/entity/Q37564440

about

The binding landscape of a partially-selective isopeptidase inhibitor with potent pro-death activity, based on the bis(arylidene)cyclohexanone scaffold.

P2860

Q50130103-07E36DA8-0027-4695-8D40-BFD711CD2A67

P2860

The isopeptidase inhibitor 2cPE triggers proteotoxic stress and ATM activation in chronic lymphocytic leukemia cells.

http://www.wikidata.org/entity/Q37564440

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 31 May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The isopeptidase inhibitor 2cP ...... ic lymphocytic leukemia cells.

@en

The isopeptidase inhibitor 2cP ...... ic lymphocytic leukemia cells.

@nl

type

label

The isopeptidase inhibitor 2cP ...... ic lymphocytic leukemia cells.

@en

The isopeptidase inhibitor 2cP ...... ic lymphocytic leukemia cells.

@nl

prefLabel

The isopeptidase inhibitor 2cP ...... ic lymphocytic leukemia cells.

@en

The isopeptidase inhibitor 2cP ...... ic lymphocytic leukemia cells.

@nl

P1433

Q37564440-8BFCFD79-651C-4BC0-B827-A9E63B765E54

P1476

Q37564440-332B67AB-06E3-47FD-9893-D746EC5F5673

P2093

Q37564440-0BA79DAC-C412-4A86-95FA-30B513A0DBE4

Q37564440-1FC9522A-4FCC-41C1-B1A9-83AB16E6DD2C

Q37564440-4792B143-FA85-416A-831B-251FDB0DD3E4

Q37564440-C36D16EC-87D4-4466-9213-71CE7258F3EF

Q37564440-D6A34580-7095-460C-B641-ED2AE393DA8F

Q37564440-E886028E-E67E-4992-9CA3-6F044B9ADB9F

Q37564440-ED5A423F-8480-4C4E-84D8-48CF781B596C

Q37564440-FED65B2E-7B0F-4C41-873B-380E22118730

P2860

Q37564440-09A82E47-CB13-4A8E-B444-279435633D72

Q37564440-0AD68660-E3CA-4F5C-902D-89ABFB78DFF7

Q37564440-0E6F6FFA-CE7A-4A3A-8405-E3B7B5B438AA

Q37564440-1720CDDD-B4C9-4FAC-937A-B00ED4C4989A

Q37564440-2020E562-C37F-4EB7-A262-AAC82CA7A810

Q37564440-24088C68-0444-4000-B44F-660D8EEF76A9

Q37564440-27FD2DE3-BB4F-41F9-8AB1-E7E254A48173

Q37564440-2CA646CD-146E-48F5-92E6-87EE84CB0227

Q37564440-30172AA6-D0E6-46E8-97C3-88BF134289CD

Q37564440-3509C032-9A8E-40D2-ABB1-D620CC5C6929

P304

Q37564440-4DBB68EB-3633-44F2-B134-0701BC265D46

P31

Q37564440-B7008082-28E8-4630-8146-F3FF01D6D97F

P356

Q37564440-2090F6A0-0BBD-4E9F-8B83-D6BE51322D80

P407

Q37564440-E878D206-CCFC-4499-8CF5-5D845E0D10F8

P433

Q37564440-7CFC8156-B06D-4012-9D88-0DF0864270A1

P478

Q37564440-E314B334-F596-4865-B1D9-E8168DD97157

P50

Q37564440-27968FE4-33B1-4826-A984-0E26DB7A164C

Q37564440-388AC7DE-50D9-4F30-860F-F75554036273

Q37564440-508FC762-770D-4034-8A4D-0AF935F2C07F

Q37564440-5F6AF12D-0ABD-4C2A-82AD-382FD7F6BD69

Q37564440-E890FFC0-DA79-4F46-AEFA-8F59F35238D4

P577

Q37564440-A64EA3DD-1871-40CA-850B-2E0F0801389D

P698

Q37564440-3AEE735C-4419-478E-B81B-2C92CB0AC8FC

P921

Q37564440-80E7C344-661D-44C8-B04F-A652A3E5830D

Q37564440-FCBA16A6-0F81-4710-B5E1-849D451F183C

P932

Q37564440-A24F662B-729B-4173-B504-677C81D5ECD1

P356

ONCOTARGET.9742

P1433

P1476

The isopeptidase inhibitor 2cP ...... ic lymphocytic leukemia cells.

@en

P2093

Andrea Sgorbissa

http://www.w3.org/2001/XMLSchema#string

Andrea Tomasella

http://www.w3.org/2001/XMLSchema#string

Domenico Delia

http://www.w3.org/2001/XMLSchema#string

Gianpietro Semenzato

http://www.w3.org/2001/XMLSchema#string

Raffaella Picco

http://www.w3.org/2001/XMLSchema#string

Rossella Manfredini

http://www.w3.org/2001/XMLSchema#string

Sonia Ciotti

http://www.w3.org/2001/XMLSchema#string

Valentina Trimarco

http://www.w3.org/2001/XMLSchema#string

P2860

ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair

RETRACTED: Selective killing of cancer cells by a small molecule targeting the stress response to ROS

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

Targeted inhibition of the deubiquitinating enzymes, USP14 and UCHL5, induces proteotoxic stress and apoptosis in Waldenström macroglobulinaemia tumour cells

Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment

Caspase-3 and caspase-7 but not caspase-6 cleave Gas2 in vitro: implications for microfilament reorganization during apoptosis

Differential Noxa/Mcl-1 balance in peripheral versus lymph node chronic lymphocytic leukemia cells correlates with survival capacity

Genomic instability--an evolving hallmark of cancer

RETRACTED: Antioncogenic and Oncogenic Properties of Nrf2 in Arsenic-induced Carcinogenesis

Identification of new compounds that trigger apoptosome-independent caspase activation and apoptosis.

P304

45429-45443

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.9742

http://www.w3.org/2001/XMLSchema#string

P407

P433

29

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Fabio Benedetti

Claudio Brancolini

Federica Frezzato

P577

2016-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27259251

http://www.w3.org/2001/XMLSchema#string

P921

P932

5216732

http://www.w3.org/2001/XMLSchema#string